Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTERNATIONAL BUSINESS MACHINES CORPORATION

(IBM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

International Business Machines : IBM Digital Health Pass To Integrate With CLX Health's TrustAssure Platform

06/18/2021 | 08:30am EDT

Integration intended to streamline COVID-19 testing process and enable secure, verifiable digital credentials.

IBM (NYSE: IBM) and CLX Health today announced plans to integrate IBM Digital Health Pass with CLX Health's TrustAssure platform to help provide individuals with a seamless, secure way to locate and schedule a COVID-19 test with a provider and create a verifiable credential to use, if needed, when returning to physical locations, such as an airplane, sports stadium or workplace. CLX TrustAssure is a global network of more than 15,000 labs across more than 82 countries.

The IBM Digital Health Pass is designed to enable organizations to verify COVID-19 test results or vaccine administration for employees, customers and visitors entering their site, such as a sports stadium, airplane, university, government building or workplace. Relying on a combination of encryption, QR codes and blockchain technology, the IBM Digital Health Pass is a secured, voluntary digital alternative to paper test results or vaccination cards and provides another option, if needed, for individuals to share that they have tested negative or been vaccinated for COVID-19.

The TrustAssure Provider Lab Portal powered by CLX Health allows individuals access to their lab and diagnostic data anytime, from anywhere. Built on a secure, unified platform, the web-based portal is interactive and easy to navigate. The planned integration of the IBM Digital Health Pass will mean that once an individual's COVID-19 test is complete, the individual will receive their results and can then opt to create a verifiable credential to add to a secure digital wallet on their smartphone. Additionally, the platform will allow for paper-to-digital scan and validation of COVID-19 vaccine cards so individuals can upload those credentials into their wallet to easily store and share them, if needed, via a verified QR code.

'We are pleased to work with CLX Health to help individuals verify their COVID-19 health credentials, if needed, in a way that preserves privacy of their personal health information,' said Eric Piscini, Vice President, Emerging Business Networks, IBM Watson Health. 'By working together, we can help enable a smoother, more efficient experience for travellers, fans and employees using the IBM Digital Health Pass.'

'CLX Health is working closely with IBM and its Digital Health Pass to issue verifiable credentials for COVID-19 test results,' said Joseph Gonzalez, Chief Strategy Officer for CLX Health. 'This is an important step in establishing an end-to-end solution that could add operational efficiency to our daily activities and improve upon convenience and safety overall.'

About CLX Health

For more information about TrustAssure visit, www.trustassure.com

CLX Health, a privately and wholly owned SiriusIQ company, delivers a clinically sound, cloud-based, multi-stakeholder solution which manages a COVID-19 testing ecosystem of physicians, clinics, hospitals, laboratories, and consumers. CLX Health's TrustAssureO Global Network of COVID-19 testing partners and providers offers over 5,000 locations across the United States and greater than 15,000 locations in over 82 countries world-wide to support various 'ready to' solutions for work, entertainment, and travel related engagements.

About IBM

For more information about IBM visit, www.ibm.com.

IBM's statements regarding its plans, directions, and intent are subject to change or withdrawal without notice at IBM's sole discretion. Information regarding potential future products is intended to outline our general product direction and it should not be relied on in making a purchasing decision. The information mentioned regarding potential future products is not a commitment, promise, or legal obligation to deliver any material, code or functionality. Information about potential future products may not be incorporated into any contract. The development, release, and timing of any future features or functionality described for our products remains at our sole discretion.

Media Contacts

Carolyn Castel

857-337-0601

carolyn.castel@ibm.com

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about INTERNATIONAL BUSINESS MACHINES CORPORATION
07/30INTERNATIONAL BUSINESS MACHINES : IBM and The Michael J. Fox Foundation use AI t..
PU
07/29IBM : 's The Weather Company Continues to Be the World's Most Accurate Forecaste..
PR
07/28INTERNATIONAL BUSINESS MACHINES : Kyndryl Names David Wyshner As Chief Financial..
PR
07/28IBM Names David Wyshner as Chief Financial Officer of Kyndryl
CI
07/28INTERNATIONAL BUSINESS MACHINES : MIT - Keylime security software is deployed to..
AQ
07/28IBM and SAP SE to Help Financial Institutions Accelerate Cloud Adoption to Mo..
CI
07/28COST OF DATA BREACHES IN CANADA HIT : Ibm
AQ
07/28IBM REPORT : Cost of a Data Breach Hits Record High During Pandemic
PR
07/27INTERNATIONAL BUSINESS MACHINES : Management's discussion and analysis
AQ
07/27IBM : Board Approves Regular Quarterly Cash Dividend
BU
More news
Financials (USD)
Sales 2021 75 218 M - -
Net income 2021 6 926 M - -
Net Debt 2021 46 531 M - -
P/E ratio 2021 18,3x
Yield 2021 4,46%
Capitalization 126 B 126 B -
EV / Sales 2021 2,30x
EV / Sales 2022 2,23x
Nbr of Employees 345 900
Free-Float 39,8%
Chart INTERNATIONAL BUSINESS MACHINES CORPORATION
Duration : Period :
International Business Machines Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTERNATIONAL BUSINESS MACHINES CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 140,96 $
Average target price 149,14 $
Spread / Average Target 5,81%
EPS Revisions
Managers and Directors
Arvind Krishna Chairman & Chief Executive Officer
James J. Kavanaugh Chief Financial Officer & Senior VP-Operations
Juan Antonio Zufiria Senior VP-Global Technology Services
Kathryn W. Guarini Chief Information Officer
Michael L. Eskew Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INTERNATIONAL BUSINESS MACHINES CORPORATION11.98%126 345
ACCENTURE PLC21.62%201 453
TATA CONSULTANCY SERVICES LTD.10.64%157 592
INFOSYS LIMITED28.24%91 883
AUTOMATIC DATA PROCESSING, INC.18.52%88 820
SNOWFLAKE INC.-5.57%78 687